Please assess the completion status of the following clinical trial:

Trial Title: Oxytocin Via Intramuscular Injection and Intravenous Bolus or Infusion for Prevention of Postpartum Hemorrhage

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* All women who present in active labor for a live birth at the study hospital will be considered for participation in the study~Exclusion Criteria:~* Planned or transferred for delivery via Cesarean section~* Administration of a pre-delivery uterotonic to induce or augment labor~* Unable to provide informed consent due to mental impairment, distress during labor or other reason

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 45 Years
- Healthy Volunteers: t

Study Arms:
- IV infusion (Type: ACTIVE_COMPARATOR): Oxytocin 10 IU will be administered by IV infusion according to randomization assignment as soon as possible after delivery of the baby.
- IV bolus (Type: ACTIVE_COMPARATOR): Oxytocin 10 IU will be administered by IV bolus according to randomization assignment as soon as possible after delivery of the baby.
- IM injection (Type: ACTIVE_COMPARATOR): Oxytocin 10 IU will be administered by IM injection according to randomization assignment as soon as possible after delivery of the baby.

Based on this trial design, predict the completion outcome and termination type (if applicable).